1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
CPIC 2024 Pilot and Feasibility Program is sponsored by Rare Diseases Clinical Research Network (RDCRN). This program focuses on projects to eliminate the disease burden associated with rare pediatric viral diseases, specifically congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and human parechovirus (HPeV) sepsis.
Get alerted about grants like this
Get emailed when new opportunities from “Rare Diseases Clinical Research Network (RDCRN)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: This program is primarily intended to support full-time faculty who are early-stage investigators. Faculty with previous or active K-awards are eligible and encouraged to apply. Confirm the full requirements in the official notice before applying.
CPIC 2024 Pilot and Feasibility Program is funded by Rare Diseases Clinical Research Network (RDCRN). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
FY27 GLIA-CTN Career Development Award is sponsored by Rare Diseases Clinical Research Network (RDCRN) - GLIA-CTN. This is a mentored award designed to provide protected time for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. Argininosuccinic aciduria can have neurological implications, and gene therapy research that touches on neurological aspects or underlying metabolic pathways relevant to leukodystrophies could be a fit.
BDCRC Early Career Investigator Grant is sponsored by Rare Diseases Clinical Research Network (RDCRN). The Early Career Investigator Grants (ECIG) address training needs in rare disease research by providing specialized education in the complexities of clinical research in the neuronal ceroid lipofuscinoses (NCLs). While primarily focused on NCLs, the general aim of supporting early career investigators in rare disease research could potentially be relevant if the proposed research also contributes to the broader understanding of rare autoimmune conditions.
Rare Disease Pilot Grants and Other Requests for Applications (ARISEN Pilot Research Grant) is sponsored by Rare Diseases Clinical Research Network (RDCRN) - Autoimmunity, Rasmussen's, Inflammation & Status Epilepticus research Network (ARISEN). The ARISEN network invites applications for pilot research projects that accelerate clinical research in rare diseases aligned with the consortium's mission. While focused on autoimmune encephalitis, Rasmussen syndrome, and NORSE/FIRES, research into related rare diseases with similar underlying mechanisms might be considered.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
NSF's Arctic Research Opportunities solicitation funds roughly 75 awards a year — up to $50 million — across six program areas from natural sciences to social sciences to the Arctic Observing Network. The July 15, 2026 target date is not a hard deadline, and understanding that distinction is the first strategic decision an Arctic researcher makes. Here is how the six doors differ and how to choose the right one.
Read articleOn June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read articlePAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read article